Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 55
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Adjuvant Chemotherapy with DTIC vs Chemoimmunotherapy with DTIC/MER in Stage III/IV Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
UMCC-7411
2.
Phase III Surgery and/or Chemotherapy with DRB and/or Immunotherapy with MER and Mononuclear Cell Transfusions for Hairy Cell Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MDA-DT-8010
Last Modified:
11/22/2005
3.
Phase III Individualized Chemotherapy of Adult Acute Leukemia Based on Predicted Outcome to Remission Induction and Maintenance Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 18
MDA-DT-7995
NCI-D81-043-066
4.
Phase III Chemotherapy with CTX/MTX/VCR/5-FU/PRED with or without BCG Immunotherapy for Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
CLB-7481
5.
Phase III Chemotherapy with ARA-C/DMN, ARA-C/TG/DMN, ARA-C/TG, or ARA-C/VCR/DM & MER-BCG Immunotherapy for Acute Myelocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
any age
NCI
CLB-7521
CALGB-7521
6.
Phase III Chemotherapy with VCR/CTX/ADR, Radiotherapy and MER-BCG Immunotherapy for Neuroblastoma, Stages III and IV
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
1 to 18
NCI
CLB-7541
Last Modified:
7/3/2007
7.
Adjuvant Chemotherapy with CTX/MTX/5-FU, CTX/MTX/5-FU/VCR/PRED and MER-BCG Immunotherapy after Mastectomy for Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 75
NCI
CLB-7581
8.
Phase III VCR/L-ASP/PRED & DNM Induction, 6-MP/MTX/VCR/PRED Maintenance & MER-BCG for Acute Lymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
20 and over
NCI
CLB-7612
9.
Phase III Chemotherapy with DNM/HU/6-MP/CTX/PRED and Immunotherapy with MER-BCG for Resistant Chronic Granulocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
CLB-7631
10.
Phase III Chemotherapy with ADR or CTX/VCR/DTIC with or without MER-BCG Immunotherapy for Soft Tissue Sarcomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
CLB-7681
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute